Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Ramundo

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
European Thyroid Journal|April 8, 2020
Taller-Than-Wide Shape: A New Definition Improves the Specificity of TIRADS SystemsGiorgio Grani, Livia Lamartina, Valeria Ramundo, et al.
Clinical Endocrinology|September 27, 2012
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PETVincenzo Marotta, Valeria Ramundo, Luigi Camera, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2019
Thyroid Cancer Patients With No Evidence of Disease: The Need for Repeat Neck UltrasoundGiorgio Grani, Valeria Ramundo, Rosa Falcone, et al.
The Journal of Clinical Endocrinology and Metabolism|October 10, 2018
Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the "Right" TIRADSGiorgio Grani, Livia Lamartina, Valeria Ascoli, et al.
Cancers|July 18, 2020
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the ThyroidValeria Pecce, Antonella Verrienti, Luana Abballe, et al.
Endocrine|January 4, 2014
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomasFrancesca Marciello, Carolina Di Somma, Michela Del Prete, et al.
Clinical Endocrinology|May 20, 2008
Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patientsAntongiulio Faggiano, Lidice Brandao Tavares, Libuse Tauchmanova, et al.
Thyroid : Official Journal of the American Thyroid Association|March 7, 2009
Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablationStefano Spiezia, Roberto Garberoglio, Francesco Milone, et al.
Journal of Cellular and Molecular Medicine|April 1, 2015
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1Luisa Circelli, Valeria Ramundo, Vincenzo Marotta, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 7, 2012
Limitations of Chromogranin A in clinical practiceVincenzo Marotta, Vincenzo Nuzzo, Teresa Ferrara, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
European Thyroid Journal|April 8, 2020
Taller-Than-Wide Shape: A New Definition Improves the Specificity of TIRADS SystemsGiorgio Grani, Livia Lamartina, Valeria Ramundo, et al.
Clinical Endocrinology|September 27, 2012
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PETVincenzo Marotta, Valeria Ramundo, Luigi Camera, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2019
Thyroid Cancer Patients With No Evidence of Disease: The Need for Repeat Neck UltrasoundGiorgio Grani, Valeria Ramundo, Rosa Falcone, et al.
The Journal of Clinical Endocrinology and Metabolism|October 10, 2018
Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the "Right" TIRADSGiorgio Grani, Livia Lamartina, Valeria Ascoli, et al.
Cancers|July 18, 2020
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the ThyroidValeria Pecce, Antonella Verrienti, Luana Abballe, et al.
Endocrine|January 4, 2014
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomasFrancesca Marciello, Carolina Di Somma, Michela Del Prete, et al.
Clinical Endocrinology|May 20, 2008
Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patientsAntongiulio Faggiano, Lidice Brandao Tavares, Libuse Tauchmanova, et al.
Thyroid : Official Journal of the American Thyroid Association|March 7, 2009
Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablationStefano Spiezia, Roberto Garberoglio, Francesco Milone, et al.
Journal of Cellular and Molecular Medicine|April 1, 2015
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1Luisa Circelli, Valeria Ramundo, Vincenzo Marotta, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 7, 2012
Limitations of Chromogranin A in clinical practiceVincenzo Marotta, Vincenzo Nuzzo, Teresa Ferrara, et al.
Pageof 5